The biology and role of CD44 in cancer progression: therapeutic implications
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The biology and role of CD44 in cancer progression: therapeutic implications
Authors
Keywords
CD44, Cancer, Signaling transduction, Tumorigenicity, Epithelial to mesenchymal transition (EMT), Cancer therapy
Journal
Journal of Hematology & Oncology
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-10
DOI
10.1186/s13045-018-0605-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin targets gastric cancer stem cells
- (2017) Sarah Courtois et al. EUROPEAN JOURNAL OF CANCER
- ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis
- (2017) Mirco Compagnone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth
- (2017) Jingying Zheng et al. Theranostics
- Nanoparticle Targeting CD44-Positive Cancer Cells for Site-Specific Drug Delivery in Prostate Cancer Therapy
- (2016) Wen-Ying Huang et al. ACS Applied Materials & Interfaces
- Iodinated hyaluronic acid oligomer-based nanoassemblies for tumor-targeted drug delivery and cancer imaging
- (2016) Jae-Young Lee et al. BIOMATERIALS
- KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis
- (2016) Yongmin Yan et al. CANCER RESEARCH
- Role of deltaNp63posCD44vposcells in the development of N-nitroso-tris-chloroethylurea-induced peripheral-type mouse lung squamous cell carcinomas
- (2016) Shotaro Yamano et al. CANCER SCIENCE
- Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells
- (2016) Tao Yin et al. CELLULAR IMMUNOLOGY
- Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205)
- (2016) Kohei Shitara et al. Gastric Cancer
- Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling
- (2016) Alexandra Matzke-Ogi et al. GASTROENTEROLOGY
- Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks inex vivoculture
- (2016) Fanny Grillet et al. GUT
- The flavonoid apigenin reduces prostate cancer CD44 + stem cell survival and migration through PI3K/Akt/NF-κB signaling
- (2016) Suat Erdogan et al. LIFE SCIENCES
- MicroRNA-143 targets CD44 to inhibit breast cancer progression and stem cell-like properties
- (2016) ZHUANGQING YANG et al. Molecular Medicine Reports
- MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer
- (2016) N Bucay et al. ONCOGENE
- Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner
- (2016) J-Y Guo et al. ONCOGENE
- FOXO3 is essential for CD44 expression in pancreatic cancer cells
- (2016) M Kumazoe et al. ONCOGENE
- Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer
- (2016) Keita Kobayashi et al. ONCOLOGY REPORTS
- Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells
- (2016) Igor Bryukhovetskiy et al. Oncology Letters
- A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth
- (2016) Jihyun Park et al. Oncotarget
- Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance
- (2016) Rebecca Bellerby et al. Frontiers in Oncology
- Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation
- (2015) Garth H. Rauscher et al. BMC CANCER
- CD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cells
- (2015) KeeSoo Nam et al. CELLULAR SIGNALLING
- Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer
- (2015) S. Banerjee et al. CLINICAL CANCER RESEARCH
- Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growth
- (2015) Joji Iida et al. EXPERIMENTAL CELL RESEARCH
- ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis
- (2015) Lidong Wang et al. GENES & DEVELOPMENT
- FOXP3 suppresses breast cancer metastasis through downregulation of CD44
- (2015) Cun Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Phase 1 study of APTO-253 HCl, an inducer of KLF4, in patients with advanced or metastatic solid tumors
- (2015) Andrea Cercek et al. INVESTIGATIONAL NEW DRUGS
- Hyaluronan Controls the Deposition of Fibronectin and Collagen and Modulates TGF-β1 Induction of Lung Myofibroblasts
- (2015) Stephen P. Evanko et al. MATRIX BIOLOGY
- Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts
- (2015) James R. Hernandez et al. MEDICAL ONCOLOGY
- CD44 Regulates Pancreatic Cancer Invasion through MT1-MMP
- (2015) Wei Jiang et al. MOLECULAR CANCER RESEARCH
- Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal
- (2015) Frida Holm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma
- (2015) Yan Gao et al. Scientific Reports
- Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells
- (2015) Theerawut Chanmee et al. Frontiers in Oncology
- Perspectives of CD44 targeting therapies
- (2014) V. Orian-Rousseau et al. ARCHIVES OF TOXICOLOGY
- Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells
- (2014) Walhan Alshaer et al. BIOCONJUGATE CHEMISTRY
- Smoothened activates breast cancer stem-like cell and promotes tumorigenesis and metastasis of breast cancer
- (2014) Lixia Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
- (2014) M Ozawa et al. BRITISH JOURNAL OF CANCER
- CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
- (2014) W. M. Lau et al. CANCER RESEARCH
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth
- (2014) Alexander Pietras et al. Cell Stem Cell
- Regulation of alternative splicing of CD44 in cancer
- (2014) Lubomir Prochazka et al. CELLULAR SIGNALLING
- CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
- (2014) Zhonghu Li et al. Diagnostic Pathology
- Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice
- (2014) Ling Li et al. GASTROENTEROLOGY
- A Novel CD44-binding Peptide from the Pro-Matrix Metalloproteinase-9 Hemopexin Domain Impairs Adhesion and Migration of Chronic Lymphocytic Leukemia (CLL) Cells
- (2014) Estefanía Ugarte-Berzal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients
- (2014) Yue Qiu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Preparation of Chondroitin Sulfate-g-poly(ε-caprolactone) Copolymers as a CD44-Targeted Vehicle for Enhanced Intracellular Uptake
- (2014) Yu-Sheng Liu et al. MOLECULAR PHARMACEUTICS
- Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells
- (2014) SANGMIN KIM et al. ONCOLOGY REPORTS
- DNA Aptamers against Exon v10 of CD44 Inhibit Breast Cancer Cell Migration
- (2014) Joji Iida et al. PLoS One
- A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer
- (2014) Alakesh Bera et al. PLoS One
- CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance
- (2014) Jie Ni et al. PROSTATE
- Diverse matrix metalloproteinase functions regulate cancer amoeboid migration
- (2014) Jose L. Orgaz et al. Nature Communications
- Assessing the in Vivo Efficacy of Doxorubicin Loaded Hyaluronan Nanoparticles
- (2013) Mohammad H. El-Dakdouki et al. ACS Applied Materials & Interfaces
- Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection
- (2013) Bing-sheng Sun et al. ANNALS OF THORACIC SURGERY
- Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity
- (2013) Elisa Dalla Pozza et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia
- (2013) O. Fedorchenko et al. BLOOD
- CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
- (2013) Guoqiang Chang et al. Cancer Cell International
- Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer
- (2013) L Zou et al. CANCER GENE THERAPY
- TGF- Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
- (2013) T.-L. Yeung et al. CANCER RESEARCH
- Cancer Stem–like Cell Marker CD44 Promotes Bone Metastases by Enhancing Tumorigenicity, Cell Motility, and Hyaluronan Production
- (2013) Toru Hiraga et al. CANCER RESEARCH
- Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation
- (2013) Takatsugu Ishimoto et al. CARCINOGENESIS
- Antitumor activity of hyaluronic acid–selenium nanoparticles in Heps tumor mice models
- (2013) Yuena Ren et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- CD147, CD44, and the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway Cooperate to Regulate Breast Epithelial Cell Invasiveness
- (2013) G. Daniel Grass et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Hyaluronic Acid Receptor CD44 Coordinates Normal and Metaplastic Gastric Epithelial Progenitor Cell Proliferation
- (2013) Shradha S. Khurana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ETS-1-mediated Transcriptional Up-regulation of CD44 Is Required for Sphingosine-1-phosphate Receptor Subtype 3-stimulated Chemotaxis
- (2013) Wenliang Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition
- (2013) J Park et al. ONCOGENE
- Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling
- (2013) J Zeilstra et al. ONCOGENE
- Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases
- (2013) J Ueda et al. ONCOGENE
- Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44
- (2013) S. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibronectin extra domain A (EDA) sustains CD133+/CD44+ subpopulation of colorectal cancer cells
- (2013) Juanjuan Ou et al. Stem Cell Research
- CD44 Expressed on Cancer-Associated Fibroblasts Is a Functional Molecule Supporting the Stemness and Drug Resistance of Malignant Cancer Cells in the Tumor Microenvironment
- (2013) Yumi Kinugasa et al. STEM CELLS
- Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44
- (2013) K Fuchs et al. Cell Death & Disease
- TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion
- (2013) Allal Ouhtit et al. Journal of Cancer
- Lipid Raft Association Restricts CD44-Ezrin Interaction and Promotion of Breast Cancer Cell Migration
- (2012) Simona Donatello et al. AMERICAN JOURNAL OF PATHOLOGY
- Detection and Clinical Significance of CD44v6 and Integrin-β1 in Pancreatic Cancer Patients using a Triplex Real-Time RT-PCR Assay
- (2012) Gang Zhou et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells
- (2012) Dhanya Nambiar et al. CANCER LETTERS
- SOX4 Induces Epithelial-Mesenchymal Transition and Contributes to Breast Cancer Progression
- (2012) J. Zhang et al. CANCER RESEARCH
- Distinct microRNA Expression Profiles in Prostate Cancer Stem/Progenitor Cells and Tumor-Suppressive Functions of let-7
- (2012) C. Liu et al. CANCER RESEARCH
- Reciprocal Interactions between Tumor-Associated Macrophages and CD44-Positive Cancer Cells via Osteopontin/CD44 Promote Tumorigenicity in Colorectal Cancer
- (2012) G. Rao et al. CLINICAL CANCER RESEARCH
- CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis
- (2012) A. Serafino et al. CURRENT CANCER DRUG TARGETS
- Snail Represses the Splicing Regulator Epithelial Splicing Regulatory Protein 1 to Promote Epithelial-Mesenchymal Transition
- (2012) Lauren M. Reinke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma
- (2012) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD44 promotes Kras-dependent lung adenocarcinoma
- (2012) P Zhao et al. ONCOGENE
- Hyaluronan Oligomers-HPMA Copolymer Conjugates for Targeting Paclitaxel to CD44-Overexpressing Ovarian Carcinoma
- (2012) Gal Journo-Gershfeld et al. PHARMACEUTICAL RESEARCH
- PDGF Suppresses the Sulfation of CD44v and Potentiates CD44v-Mediated Binding of Colon Carcinoma Cells to Fibrin under Flow
- (2012) Christina S. Alves et al. PLoS One
- Efficient Engineering of Vascularized Ectopic Bone from Human Embryonic Stem Cell–Derived Mesenchymal Stem Cells
- (2012) Hagit Domev et al. TISSUE ENGINEERING PART A
- Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell
- (2012) Toshifumi Yae et al. Nature Communications
- Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas
- (2011) Spyros S Skandalis et al. BMC CANCER
- Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters
- (2011) Junlin Li et al. BMC CANCER
- CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
- (2011) Takatsugu Ishimoto et al. CANCER CELL
- ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness
- (2011) N. P. Judd et al. CANCER RESEARCH
- CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
- (2011) Rhonda L. Brown et al. JOURNAL OF CLINICAL INVESTIGATION
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP
- (2011) K Horiguchi et al. ONCOGENE
- Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by Methyl-CpG binding proteins and histone modifications
- (2010) Imke Müller et al. BMC CANCER
- Nuclear β-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells
- (2010) Masahiro Uchino et al. BMC CANCER
- CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma
- (2010) Y. Xu et al. CANCER RESEARCH
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- Stromal Hyaluronan Interaction with Epithelial CD44 Variants Promotes Prostate Cancer Invasiveness by Augmenting Expression and Function of Hepatocyte Growth Factor and Androgen Receptor
- (2010) Shibnath Ghatak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion
- (2010) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ATF3, an adaptive-response gene, enhances TGF signaling and cancer-initiating cell features in breast cancer cells
- (2010) X. Yin et al. JOURNAL OF CELL SCIENCE
- A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis
- (2009) M. Tremmel et al. BLOOD
- Hyaluronan, CD44, and Emmprin Regulate Lactate Efflux and Membrane Localization of Monocarboxylate Transporters in Human Breast Carcinoma Cells
- (2009) Mark G. Slomiany et al. CANCER RESEARCH
- CD44+slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2in gastric tumorigenesis
- (2009) Takatsugu Ishimoto et al. CANCER SCIENCE
- Hyaluronan substratum induces multidrug resistance in human mesenchymal stem cells via CD44 signaling
- (2009) Chi-Mou Liu et al. CELL AND TISSUE RESEARCH
- Delivery of CD44 shRNA/Nanoparticles within Cancer Cells
- (2009) Suniti Misra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Calcitriol Derivatives with Two Different Side Chains at C-20. V. Potent Inhibitors of Mammary Carcinogenesis and Inducers of Leukemia Differentiation†
- (2009) Hubert Maehr et al. JOURNAL OF MEDICINAL CHEMISTRY
- ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing
- (2009) Claude C. Warzecha et al. MOLECULAR CELL
- Zerumbone Down-regulates Chemokine Receptor CXCR4 Expression Leading to Inhibition of CXCL12-Induced Invasion of Breast and Pancreatic Tumor Cells
- (2008) Bokyung Sung et al. CANCER RESEARCH
- Hyaluronic Acid Synthase-1 Expression Regulates Bladder Cancer Growth, Invasion, and Angiogenesis through CD44
- (2008) R. Golshani et al. CANCER RESEARCH
- Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression
- (2008) Samuel Godar et al. CELL
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates β-Catenin Signaling and NFκB-specific Transcription Activity Leading to MDR1 and Bcl-xLGene Expression and Chemoresistance in Breast Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma
- (2008) Herbert Riechelmann et al. ORAL ONCOLOGY
- Targeting CD44v6 Expressed in Head and Neck Squamous Cell Carcinoma: Preclinical Characterization of an 111In-Labeled Monoclonal Antibody
- (2008) Karl Sandström et al. TUMOR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started